The global silver wound dressing market size was valued at USD 810.2 million in 2019 and is expected to witness a CAGR of 5.7% over the forecast period. The demand for silver wound dressing in on a rise owing to the increasing prevalence of chronic diseases, technological advancement, rising cases of accidents, trauma, and rising geriatric population.
Rising prevalence of chronic and acute wounds and introduction of technological advanced products are the major factors anticipated to drive the market. For instance, in October 2019, Imbed Biosciences Inc. was awarded USD 1.5 million grant at the National Institutes of Health (NIH) for research and development of bioresorbable wound dressing with gallium and silver metal ions. Such new technologically advanced products are expected to positively impact market growth over the forecast period. Furthermore, rising prevalence of chronic wounds is also anticipated to drive the market over the forecast period. As per the data reported by Centers for Disease Control and Prevention (CDC), in 2018, six out of ten Americans suffer from at least one chronic disease such as cancer, cardiovascular diseases, and diabetes. Such high prevalence rate of chronic diseases in the U.S. is the major cause of the high disability and death rates in the country. Cancer is considered to be a healthcare burden in the U.S. as it is one of the leading causes of death in the country. According to the estimates of Cancer Organization, in 2018, cancer was the second leading cause of deaths and about 1,735,350 new cancer cases were registered in the U.S. In addition, nearly 4,700 new cases of cancer are diagnosed each day in the country.
Globally, the number of surgeries is also increasing owing to which the prevalence rate of acute wounds is also increasing. The silver based wound dressing, thus, are increasingly being used to prevent surgical site infections, as it allows rapid healing. Most surgical wounds, post-cancer surgery, are relatively deep and large, releasing exudates that require regular management. The silver wound care product helps to manage large wounds, thereby significantly reducing the risk of infection. Thus, rising incidence of chronic diseases is expected to boost the demand for these products, thereby propelling market growth, globally.
The rising cases of traumatic events and road accidents are also one of the major reasons for the growth of the market. For instance, as per the American Association for the Surgery of Trauma, in 2017, around 1.2 million people got killed globally, which is around 3,242 people per day. Such cases are expected to surge the demand for rapid wound healing products.
Key players are also adopting various strategies to strengthen their position in the industry. For instance, in February 2019, GEMCO Medical launched GEMCORE360, the brand of advanced wound care products. The portfolio includes silver alginate dressings, hydrocolloid dressings, transparent thin films, alginate dressings, PHMB foam dressings, and foam dressings. Thus, such initiatives by key players are anticipated to drive the market over the forecast period.
On the basis of product, the market is segmented into traditional and advanced wound dressing. Advanced silver wound dressing has been further categorized into Silver Foam Dressing, Silver Plated Nylon Fiber Dressing, Silver Hydrogel / Hydrofibre, Silver Alginates, Nano Crystalline Silver Dressings, and others. The advanced silver wound dressing segment held the largest share in 2019 and is expected to witness the fastest growth rate over the forecast period. Advanced silver wound dressing contains antimicrobial properties that allow rapid wound healing.
Advanced silver wound dressing can be used as primary as well as secondary dressing and is suitable for managing moderate, minimal, and heavy exudates. These dressings are commonly used for surgical wounds, pressure ulcers, diabetic foot ulcers, venous leg ulcers, and burn wounds. Increase in number of acute wound cases has led to a rise in demand for silver antimicrobial wound dressing across the globe, which is expected to drive the segment.
The hospital segment held the largest share in 2019 in the silver wound dressing market. The increasing demand for the treatment of acute and chronic wounds is one of the major driving factors for the growth of the segment. In addition, increasing incidence of diabetic foot ulcers and venous leg ulcers is also anticipated to drive the segment. The silver based formulations are majorly used for rapid healing of leg ulcers. Furthermore, increasing cases of surgical wounds due to a rise in the number of surgeries is also driving the segment. Thus, these factors may fuel segment growth over the forecast period.
The home healthcare segment is expected to witness the fastest growth over the forecast period. Most of the surgeries require a prolonged recovery period, leading to frequent changing of dressing. Thus, the demand for advanced wound care products in-home healthcare settings is increasing. Moreover, geriatric and bariatric population and patients suffering from chronic wounds prefer homecare over hospital stay.
North America dominated the market in 2019. The increasing cases of road accidents, rising prevalence of chronic diseases, and the presence of several key players in the region are anticipated to drive the market in North America. In addition, the availability of skilled professionals and improvement in healthcare infrastructure is also expected to drive the market over the forecast period.
In Asia Pacific, the market is anticipated to witness the fastest growth over the forecast period. Presence of developing countries such as China, India, and Japan is anticipated to boost the market growth in the region. In addition, increasing cases of chronic diseases, especially diabetes is also expected to surge the growth of the market over the forecast period.
Prominent players in the market include Mölnlycke Health Care AB, 3M, Coloplast, Medline, and Smith and Nephew PLC. Key players are adopting various strategies such as merger and acquisitions, product launch, and partnerships to strengthen their position in the market.
For instance, in 2019, KCI-an Acelity - introduced its advanced wound dressing products, such as KERRAFOAM Gentle Border Dressing, KERRACONTACT Ag Dressing, and KERRAMAX CARE Dressing, in South Africa to expand its market presence. Acelity was later acquired by 3M. Such strategic initiatives are expected to increase the company’s market share and revenue.
Report Attribute |
Details |
Market size value in 2020 |
USD 853.92 million |
Revenue forecast in 2027 |
USD 1.3 billion |
Growth Rate |
CAGR of 5.7% from 2020 to 2027 |
Base year for estimation |
2019 |
Historical data |
2016 - 2018 |
Forecast period |
2020 - 2027 |
Quantitative units |
Revenue in USD million and CAGR from 2020 to 2027 |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors and trends |
Segments covered |
Product, end use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Russia; China; Japan; India; Australia; South Korea; Brazil; Mexico; Argentina; Colombia; South Africa; Saudi Arabia; Turkey; UAE |
Key companies profiled |
Mölnlycke Health Care AB; 3M; Coloplast; Medline; Smith & Nephew PLC |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2027. For the purpose of this study, Grand View Research has segmented the global silver wound dressing market on the basis of product, end use, and region:
Product Outlook (Revenue, USD Million, 2016 - 2027)
Traditional
Silver Bandages
Others
Advanced
Silver Foam Dressing
Silver Plated Nylon Fiber Dressing
Silver Hydrogel/Hydrofibre
Silver Alginates
Nano Crystalline Silver Dressings
Others
End-use Outlook (Revenue, USD Million, 2016 - 2027)
Hospitals
Clinics
Home Healthcare
Others
Regional Outlook (Revenue, USD Million, 2016 - 2027)
North America
The U.S.
Canada
Europe
The U.K.
Germany
France
Italy
Spain
Russia
Asia Pacific
China
Japan
India
Australia
South Korea
Latin America
Brazil
Mexico
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
Turkey
UAE
b. The global silver wound dressing market size was estimated at USD 810.17 million in 2019 and is expected to reach USD 853.92 million in 2020.
b. The global silver wound dressing market is expected to grow at a compound annual growth rate of 5.8% from 2020 to 2027 to reach USD 1.26 billion by 2027.
b. The advanced silver wound dressing segment held the largest market share of 59.86% in 2019 and is expected to witness the fastest growth rate over the forecast period.
b. Some key players operating in the silver wound dressing market include Mölnlycke Health Care AB, 3M, Coloplast, Medline, and Smith & Nephew PLC.
b. Key factors that are driving the market growth include the increasing prevalence of chronic diseases, technological advancement, rising cases of accidents & trauma, and rising geriatric population.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.
We value your investment and offer free customization with every report to fulfil your exact research needs.